News about Drug Discovery & Development

CleanNA Launches CE-IVD Product for Quick and Reliable Viral DNA and RNA Extraction

CleanNA Launches CE-IVD Product for Quick and Reliable Viral DNA and RNA Extraction

The company’s Clean Quick Viral DNA/RNA (CE-IVD) extracts viral DNA and RNA from nasopharyngeal or oropharyngeal swab samples preserved in an inactivating viral transport medium.

Drug Discovery & Development | 06/03/2024 | By Manvi 520

LTS Launches Sorrel Wearable Drug Delivery Platform with Coherus BioSciences

LTS Launches Sorrel Wearable Drug Delivery Platform with Coherus BioSciences

The platform debuts alongside Coherus' UDENYCA® on-body injector (OBI), a solution for administering pegfilgrastim-cbqv, a biosimilar pegfilgrastim utilized post-chemotherapy to mitigate infection risks.

Drug Discovery & Development | 29/02/2024 | By Manvi 1661

Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact System

Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact System

Accuray Incorporated announced that the team at Quebec's Montérégie Integrated Cancer Center, part of Charles-LeMoyne Hospital, is the first in Canada to treat cancer patients using the company's Radixact® radiation therapy delivery system.

Drug Discovery & Development | 13/02/2024 | By Manvi 273

BIOTRONIK Launches Micro Rx Catheter for Enhanced Guidewire Support in Coronary Interventions

BIOTRONIK Launches Micro Rx Catheter for Enhanced Guidewire Support in Coronary Interventions

Developed exclusively by BIOTRONIK and manufactured by IMDS, this innovative device marks a significant addition to the company's robust portfolio of interventional solutions in the US.

Drug Discovery & Development | 12/02/2024 | By Manvi 612

Boehringer Ingelheim and CBmed Forge Partnership to Advance Cancer Treatment Development

Boehringer Ingelheim and CBmed Forge Partnership to Advance Cancer Treatment Development

The partnership, unveiled with great anticipation, will harness translational medicine approaches to drive the advancement of first-in-class therapies, ultimately aiming to revolutionize the lives of individuals battling cancer.

Drug Discovery & Development | 12/02/2024 | By Manvi 523

Domrex Pharma Expands Its Reach with Launch of Domrex Pharma USA

Domrex Pharma Expands Its Reach with Launch of Domrex Pharma USA

Originating in Quebec, Domrex Pharma has successfully positioned itself as a key player in the healthcare industry, catering to hospitals, pharmacies, clinics, and long-term care facilities across Canada.

Drug Discovery & Development | 02/02/2024 | By Manvi 795

Pfizer and Glenmark Partners to Bring Treatment for Atopic Dermatitis to India

Pfizer and Glenmark Partners to Bring Treatment for Atopic Dermatitis to India

Abrocitinib, set to be launched in India under the brand names JABRYUS® and CIBINQO® by Glenmark and Pfizer, respectively, marks a breakthrough in the treatment of AD.

Drug Discovery & Development | 01/02/2024 | By Manvi 717

Turkish Cargo Elevates Pharmaceutical Logistics with Launch of TK Pharma Product Line

Turkish Cargo Elevates Pharmaceutical Logistics with Launch of TK Pharma Product Line

The introduction of its innovative products—TK Pharma Standard, TK Pharma Extra, and TK Pharma Advanced—aims to meet customer expectations by offering flexible solutions for pharmaceutical and medical consignments.

Drug Discovery & Development | 31/01/2024 | By Manvi 771

LifeSprout Signs Agreement with Boyang Trading to Develop and Commercialize Next-Generation Lumina Dermal Filler

LifeSprout Signs Agreement with Boyang Trading to Develop and Commercialize Next-Generation Lumina Dermal Filler

Lumina is the first product from LifeSprout's proprietary Regenerative Matrix platform. The technology comprises biomimetic, biocompatible, biodegradable materials engineered to look and feel like native soft tissue.

Drug Discovery & Development | 31/01/2024 | By Manvi 652

Uppaluri K&H Personalized Medicine Clinic Unveil AI platform - GeneConnectRx

Uppaluri K&H Personalized Medicine Clinic Unveil AI platform - GeneConnectRx

Uppaluri K&H Personalized Medicine Clinic Pvt Ltd., unveiled GeneConnectRx, an innovative AI platform from GenepoweRx, the diagnostic wing of the group.

Drug Discovery & Development | 09/01/2024 | By Manvi 723

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members